Delivery Order SPE2DB20D3303-SPE2DB24FA1QT
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$8.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a potential value of $3,529.88 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor to provide pharmaceutical products and medical supplies to support military treatment programs and...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $5,695.56, to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure essential pharmaceutical products and medical supplies for...
The U.S. Defense Logistics Agency (DLA) awarded a $9,920.17 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,046.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The contract has a potential value of $1,937.01 and a completion date of February 1, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $17,258.68 contract is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products to support military treatment programs and facilities. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a $3,773.44 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen, 3ml. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,573,423 units of the pharmaceutical product OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The contract has a potential value of $29,794.38 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $1,952.72 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This contract has an ultimate completion date of August 21, 2024 and is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. The $1,451.30 award has an ultimate completion date of April 8, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp as the sole contractor. The IDC serves as the primary vehicle for...